Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 3 |
2022 | 1 |
2024 | 1 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Affibody-Mediated PNA-Based Pretargeted Cotreatment Improves Survival of Trastuzumab-Treated Mice Bearing HER2-Expressing Xenografts.
J Nucl Med. 2022 Jul;63(7):1046-1051. doi: 10.2967/jnumed.121.262123. Epub 2021 Oct 28.
J Nucl Med. 2022.
PMID: 34711617
Free PMC article.
Comparative Evaluation of Novel 177Lu-Labeled PNA Probes for Affibody-Mediated PNA-Based Pretargeting.
Tano H, Oroujeni M, Vorobyeva A, Westerlund K, Liu Y, Xu T, Vasconcelos D, Orlova A, Karlström AE, Tolmachev V.
Tano H, et al.
Cancers (Basel). 2021 Jan 28;13(3):500. doi: 10.3390/cancers13030500.
Cancers (Basel). 2021.
PMID: 33525578
Free PMC article.
Item in Clipboard
Stability Enhancement of a Dimeric HER2-Specific Affibody Molecule through Sortase A-Catalyzed Head-to-Tail Cyclization.
Westerlund K, Myrhammar A, Tano H, Gestin M, Karlström AE.
Westerlund K, et al. Among authors: tano h.
Molecules. 2021 May 12;26(10):2874. doi: 10.3390/molecules26102874.
Molecules. 2021.
PMID: 34066245
Free PMC article.
Item in Clipboard
Shorter Peptide Nucleic Acid Probes Improve Affibody-Mediated Peptide Nucleic Acid-Based Pretargeting.
Westerlund K, Oroujeni M, Gestin M, Clinton J, Hani Rosly A, Tano H, Vorobyeva A, Orlova A, Eriksson Karlström A, Tolmachev V.
Westerlund K, et al. Among authors: tano h.
ACS Pharmacol Transl Sci. 2024 Apr 29;7(5):1595-1611. doi: 10.1021/acsptsci.4c00106. eCollection 2024 May 10.
ACS Pharmacol Transl Sci. 2024.
PMID: 38751640
Item in Clipboard
Preclinical Evaluation of the GRPR-Targeting Antagonist RM26 Conjugated to the Albumin-Binding Domain for GRPR-Targeting Therapy of Cancer.
Abouzayed A, Tano H, Nagy Á, Rinne SS, Wadeea F, Kumar S, Westerlund K, Tolmachev V, Eriksson Karlström A, Orlova A.
Abouzayed A, et al. Among authors: tano h.
Pharmaceutics. 2020 Oct 16;12(10):977. doi: 10.3390/pharmaceutics12100977.
Pharmaceutics. 2020.
PMID: 33081166
Free PMC article.
Item in Clipboard
Cite
Cite